NCAPH and Its Role in Glioma Progression
Author Information
Author(s): Liang Jianshen, Yun Debo, Jin Wenzhe, Fan Jikang, Wang Xuya, Wang Xisen, Li Yiming, Yu Shengping, Zhang Chen, Li Tao, Yang Xuejun
Primary Institution: Tianjin Medical University General Hospital
Hypothesis
The study investigates the role of NCAPH in glioma progression and its potential as a prognostic factor.
Conclusion
NCAPH is significantly upregulated in gliomas and promotes tumor progression through the PI3K/AKT signaling pathway.
Supporting Evidence
- NCAPH expression is significantly higher in glioma tissues compared to normal brain tissues.
- High NCAPH expression correlates with poor prognosis in glioma patients.
- NCAPH promotes glioma cell proliferation, migration, and invasion.
- NCAPH is associated with WHO grade, IDH wild-type, and non-1p/19q codeletion.
- NCAPH activates the PI3K/AKT signaling pathway in glioma cells.
Takeaway
NCAPH is a protein that helps glioma tumors grow, and if we can target it, we might be able to stop the tumors from getting worse.
Methodology
The study used bioinformatics analysis, lentiviral transfection, CCK-8 assay, colony-formation assay, transwell assay, cell wound healing assay, flow cytometry, and a nude mouse model.
Limitations
The downstream targets of NCAPH in glioma have only been briefly analyzed, and the specific mechanism of NCAPH in regulating the PI3K/AKT pathway is still unknown.
Participant Demographics
Patients with glioma, including various WHO grades and IDH statuses.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website